Bioadaptives (BDPT) Other financing activities (2014 - 2025)

Bioadaptives has disclosed Other financing activities across 7 years of filings, most recently posting $115000.0 for Q2 2025.

• Other financing activities for Q2 2025 came in at $115000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $47500.0 (changed N/A YoY), and the FY2023 annual result was -$2500.0, changed N/A from the prior year.
• Other financing activities came in at $115000.0 for Q2 2025 at Bioadaptives, up from $90000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $115000.0 in Q2 2025 to a low of -$167500.0 in Q4 2023.
• The 4-year median for Other financing activities is $42500.0 (2021), against an average of $15694.5.
• Across the five-year window, Other financing activities soared 630.71% in 2021 and plunged 86.67% in 2022, its largest moves.
• Bioadaptives' Other financing activities stood at -$28333.0 in 2021, then jumped by 135.29% to $10000.0 in 2022, then plunged by 1775.0% to -$167500.0 in 2023, then soared by 168.66% to $115000.0 in 2025.
• The last three Other financing activities figures came in at $115000.0 (Q2 2025), $90000.0 (Q1 2025), and -$167500.0 (Q4 2023), per Business Quant data.